Elias Sotirchos
esotirchos.bsky.social
Elias Sotirchos
@esotirchos.bsky.social
Reposted by Elias Sotirchos
New press release from Sanofi - tolebrutinib did NOT meet it's primary endpoint in PP-MS trial
www.sanofi.com/en/media-roo...
Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis PERSEUS phase 3 study in primary progressive multiple sclerosis did not meet its primary endpoint in delaying time to....
www.sanofi.com
December 15, 2025 at 6:28 PM
Reposted by Elias Sotirchos
#ICYMI We were joined by Dr. Elias Sotirchos to discuss vaccines in the setting of immunocompromised patients. www.youtube.com/watch?v=7VCE...

This program was made possible with support from Alexion Pharmaceuticals
Immunizations for the Immunocompromised
YouTube video by The Sumaira Foundation
www.youtube.com
April 15, 2025 at 2:43 PM
Reposted by Elias Sotirchos
#MedSky Vaccines play a crucial role in protecting immunocompromised patients & help prevent the spread of diseases.

Join us on March 25th for a discussion led by Dr. @esotirchos.bsky.social

To register, visit us02web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: Immunizations for the Immunocompromised. After registering, you will receive a confirmation email about joining the webinar.
Vaccines play a crucial role in protecting immunocompromised patients, as their weakened immune systems make them more vulnerable to infections. Vaccines also help prevent the spread of contagious dis...
us02web.zoom.us
March 12, 2025 at 1:16 PM
Reposted by Elias Sotirchos
#URGENT: #MultipleSclerosis research funding at risk: contact Congress today!

The Continuing Resolution to fund the government cuts funding by 57%
The #MS Society has an action alert urging Members of Congress to oppose these cuts here nmss.quorum.us/campaign/113...

Please take action and #share!
URGENT: MS Research Funding at Risk – Contact Congress Today
ACTION NEEDED TODAY
nmss.quorum.us
March 10, 2025 at 8:02 PM
Reposted by Elias Sotirchos
March 10, 2025 at 10:35 PM
Reposted by Elias Sotirchos
Pleased to write this editorial with Larry Steinman about a potential novel antibody in MS
www.neurology.org/doi/10.1212/...

Original manuscript here:
www.neurology.org/doi/10.1212/...
Neurology® Journals
www.neurology.org
February 13, 2025 at 5:13 AM
Excited to share out study (led by Yana Said and in collaboration with colleagues at the Mayo Clinic) reporting our real-world clinical experience with paired fixed and live CBA testing for MOG-IgG and AQP4-IgG.
onlinelibrary.wiley.com/doi/10.1002/...
Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assay
Objective To assess the real-world performance of a live (LCBA) versus a fixed (FCBA) cell-based assay for the detection of serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG...
onlinelibrary.wiley.com
February 5, 2025 at 8:54 PM
Reposted by Elias Sotirchos
A bill to break up UnitedHealth, CVS, Cigna and more has been introduced by a bipartisan group of U.S. senators and representatives.

The legislation would force insurers to sell their pharmacy businesses.

It aims to combat PBMs, pharma middlemen who drive up costs.
December 12, 2024 at 3:44 PM
jnnp.bmj.com/content/earl... This is an interesting study. Need to be careful though with potentially overinterpreting this and other retrospective observational studies purported to prove the effectiveness of early PLEX. My detailed rapid response to this article here: jnnp.bmj.com/content/earl...
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
Background Incomplete attack remission is the main cause of disability in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Apheresis therapies such as plasma exchange and immun...
jnnp.bmj.com
December 4, 2024 at 3:42 PM
Reposted by Elias Sotirchos
Time to strike the label
“Lupus Myelitis” … Forever ✅
What say you, #MedSky #RheumSky #NeuroSky?

🧠🎙️ Neurology Podcast: Dr. @esotirchos.bsky.social discusses the underlying etiologies of myelitis in patients with rheumatologic disease.
Listen now: bit.ly/48VRPwC
Myelitis Associated With Rheumatologic Disease
Dr. Stacey Clardy talks with Dr. Elias Sotirchos about the underlying etiologies of myelitis in patients with rheumatologic disease. Read the related article in . Disclosures can be found at Neurology...
bit.ly
November 20, 2024 at 3:33 PM